*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Beckman/NNP Instruments/NNP Inc./NNP ]
said/VBD 
[ it/PRP ]
will/MD phase/VB out/RP about/RB 
[ 150/CD jobs/NNS ]
in/IN 
[ its/PRP$ Bioanalytical/NNP Group/NNP ]
and/CC take/VB 
[ other/JJ steps/NNS ]
to/TO reflect/VB 
[ a/DT world-wide/JJ slowdown/NN ]
in/IN 
[ public/JJ spending/NN ]
for/IN 
[ life/NN science/NN research/NN ]
at/IN 
[ university/NN ]
and/CC 
[ government/NN laboratories/NNS ]
./. 

======================================

[ Beckman/NNP ]
,/, 
[ a/DT supplier/NN ]
of/IN 
[ diagnostic/NN ]
and/CC 
[ life/NN science/NN laboratory/NN instruments/NNS ]
and/CC related/VBN 
[ products/NNS ]
,/, said/VBD 
[ the/DT jobs/NNS ]
would/MD be/VB trimmed/VBN by/IN 
[ year/NN end/NN ]
./. 

[ The/DT company/NN ]
said/VBD 
[ it/PRP ]
would/MD require/VB 
[ the/DT group/NN ]
's/POS approximately/RB 
[ 3,000/CD remaining/JJ employees/NNS ]
to/TO take/VB 
[ five/CD vacation/NN ]
or/CC 
[ furlough/NN days/NNS ]
during/IN 
[ that/DT period/NN ]
because/IN of/IN 
[ the/DT slowdown/NN ]
./. 

======================================

[ The/DT company/NN ]
said/VBD 
[ its/PRP$ Diagnostic/NNP Systems/NNP Group/NNP ]
will/MD be/VB unaffected/JJ ,/, and/CC continues/VBZ to/TO post/VB 
[ strong/JJ sales/NNS ]
./. 

[ Sales/NNS growth/NN ]
in/IN 
[ that/DT unit/NN ]
should/MD offset/VB 
[ the/DT impact/NN ]
of/IN 
[ currency/NN exchanges/NNS ]
to/TO result/VB in/IN 
[ a/DT modest/JJ sales/NNS ]
rise/NN in/IN 
[ the/DT year/NN ]
,/, 
[ the/DT company/NN ]
said/VBD ./. 

======================================

``/`` Although/IN 
[ we/PRP ]
are/VBP experiencing/VBG 
[ difficult/JJ business/NN conditions/NNS ]
in/IN 
[ the/DT life/NN sciences/NNS ]
,/, 
[ we/PRP ]
will/MD continue/VB 
[ our/PRP$ investment/NN ]
in/IN 
[ the/DT development/NN ]
of/IN 
[ new/JJ products/NNS ]
,/, since/IN 
[ we/PRP ]
expect/VBP 
[ a/DT return/NN ]
to/TO 
[ normal/JJ business/NN ]
as/IN 
[ public/JJ spending/NN ]
for/IN 
[ bioresearch/NN ]
revives/VBZ ,/, ''/'' said/VBD 
[ Louis/NNP T./NNP Rosso/NNP ]
,/, 
[ Beckman/NNP chairman/NN ]
and/CC 
[ president/NN ]
./. 

======================================

[ Beckman/NNP ]
,/, 
[ which/WDT ]
was/VBD spun/VBN off/RP by/IN 
[ its/PRP$ former/JJ 84%-owner/JJ SmithKline/NNP Beckman/NNP Corp./NNP ]
earlier/RBR 
[ this/DT year/NN ]
,/, has/VBZ more/JJR than/IN 
[ 7,000/CD workers/NNS ]
./. 
